arrow
S

Susana Minguet

University of Freiburg
H指数:32
被引数:4,098

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Extracorporeal photopheresis for the treatment of steroid-refractory immune related adverse events from immune checkpoint inhibitor therapy: a multi-center phase Ib/II clinical trial

体外光opheresis治疗免疫检查点抑制剂疗法所致的类固醇难治性免疫相关不良反应:一项多中心Ib/II期临床试验

2026-10-230
OAAI
Distinct postnatal trajectories of mouse dendritic epidermal T cells and Langerhans cells independent of microbiota

新生小鼠树突状表皮T细胞和朗格汉斯细胞的独立于微生物群的差异性出生后轨迹

2026-01-010
OA
Menin-inhibition enhances graft-versus-leukemia effects by T-cell activation and endogenous retrovirus induction in AML

Menin抑制通过T细胞活化及内源性逆转录病毒诱导增强移植物抗白血病效应(AML)

Blood
IF23.1
2025-10-300
PRE
TCR/CD3-based synthetic antigen receptors (TCC) convey superior antigen sensitivity combined with high fidelity of activation

TCR/CD3-based合成抗原受体 (TCC) 具有优异的抗原敏感性和高保真性

2024-09-060
OAAI
Perinatal thymic-derived CD8αβ-expressing γδ T cells are innate IFN-γ producers that expand in IL-7R-STAT5B-driven neoplasms
2024-05-271
OAAI
Mutation-specific CAR T cells as precision therapy for IGLV3-21R110 expressing high-risk chronic lymphocytic leukemia

突变特异性CAR T细胞精准治疗高危慢性淋巴细胞白血病IGLV3-21R110

2024-02-024
OAAI
Dual targeting of cancer metabolome and stress antigens affects transcriptomic heterogeneity and efficacy of engineered T cells

癌症代谢组和应激抗原的双重靶向影响工程化T细胞的转录组异质性和功效

2023-11-273
PRE
A partial human LCK defect causes a T cell immunodeficiency with intestinal inflammation
2023-11-145
OAAI
Harnessing CD3 diversity to optimize CAR T cells

利用CD3多样性优化cart细胞

2023-11-0617
OAAI
MDM2 Inhibition Enhances Immune Checkpoint Inhibitor Efficacy by Increasing IL15 and MHC Class II Production
2023-04-1812
OA
Human β-defensin 2 ameliorates acute GVHD by limiting ileal neutrophil infiltration and restraining T cell receptor signaling

人 β-防御素2通过限制回肠中性粒细胞浸润和抑制T细胞受体信号来改善急性GVHD

2022-12-2110
OA